P Vanhoutte - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Vanhoutte

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Therapie|July 1, 1995

[Arterial wall: a new pharmacological and therapeutic target?]S Laurent, P Vanhoutte, I Cavero, et al.

British Journal of Pharmacology|May 15, 2001

Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugsV Bruban, J Feldman, H Greney, et al.

Lung Cancer (Amsterdam, Netherlands)|August 11, 2004

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.

Fundamental & Clinical Pharmacology|January 1, 1996

The arterial wall: a new pharmacological and therapeutic targetS Laurent, P Vanhoutte, I Cavero, et al.

Molecular Psychiatry|August 5, 2015

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbensD Y Sakae, F Marti, S Lecca, et al.

Circulation|May 1, 2023

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Therapie|July 1, 1995

[Arterial wall: a new pharmacological and therapeutic target?]S Laurent, P Vanhoutte, I Cavero, et al.

British Journal of Pharmacology|May 15, 2001

Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugsV Bruban, J Feldman, H Greney, et al.

Lung Cancer (Amsterdam, Netherlands)|August 11, 2004

Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.

Fundamental & Clinical Pharmacology|January 1, 1996

The arterial wall: a new pharmacological and therapeutic targetS Laurent, P Vanhoutte, I Cavero, et al.

Molecular Psychiatry|August 5, 2015

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbensD Y Sakae, F Marti, S Lecca, et al.

Circulation|May 1, 2023

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.

Pageof 3